#Nasojejunal

[sopranoentravesti]

Yknow, this is likely a result of having worked too long in a Pediatric Feeding Disorders Unit, and being someone who also has both a history of extreme food selectivity (thankfully grown/ trained out of) and who struggles with dysphagia/aspiration and dysmotility (from the esophagus through the colon) but I truly think Seven of Nine would have a much more difficult time adjusting to actually eating food???

Like I worked with kids who were G-Tube and occasionally nasogastric and nasojejunal tube dependent. It isn’t easy. It’s doable, there are protocols, but ??? There’s a fair amount of discomfort involved.

Like, it takes intensive occupational therapy to develop the motor skills to chew, manipulate food within your mouth, etc…you need to ensure they can swallow safely and effectively (even if they “seem fine,” silent aspiration and fatigue can be dangerous).

Then you get into trying new foods… there’s a lot of sensory stuff!! Obviously Seven is an adult, so she likely won’t demonstrate the same overwhelming neophobia that the 2-8 year olds I worked with would have! But I imagine she would probably be picky initially (especially with Neelix’s concoctions, which most of the crew found often unpalatable due to being unusual).

And as most of us with gastrointestinal issues know, that is also no picnic (hah). She likely wouldn’t have the enzymes she once had, and I’m willing to bet her microbiome was pretty starved. Probably they have a hypo for that, but it’s still an issue…

Obvious disclaimer, it is a fairly niche thing to think about (and not pretty), this is television, entertainment, and sci-fi, so maybe they can magically make it as if she was eating her whole life…

But it’s still something that I cannot stop thinking about.

[bhushans]

Exploring New Technologies in the Enteral Feeding Devices Market

The enteral feeding devices market is set for steady growth, with a projected compound annual growth rate (CAGR) of 4.0% over the forecast period. According to recent market analysis, the market is expected to increase from USD 2.8 billion in 2023 to USD 4.1 billion by 2033, reflecting the growing demand for efficient and reliable enteral feeding solutions.

Enteral feeding devices, essential for providing nutrition to patients who cannot consume food orally, are increasingly in demand due to the rising prevalence of chronic diseases, aging populations, and advancements in medical technology. These devices play a crucial role in patient care, particularly in hospitals, long-term care facilities, and home healthcare settings.

The market’s growth is driven by the continuous innovation and improvement in enteral feeding technologies, ensuring better patient outcomes and enhanced quality of care. Key players in the industry are focusing on developing more efficient, user-friendly, and safe enteral feeding solutions to meet the evolving needs of healthcare providers and patients.

Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12403

The promising future of the enteral feeding device market highlights its vital function in the healthcare industry in providing for the nutritional requirements of patients unable to swallow food. With consistent expansion and ongoing innovation, the industry is poised to significantly advance patient care across the globe.

Key Takeaways:

Market Growth: The enteral feeding devices market is projected to grow at a CAGR of 4.0% from 2023 to 2033.

Current and Future Valuation: The market holds a current valuation of US$ 2.8 billion in 2023 and is expected to reach US$ 4.1 billion by 2033.

Driving Factors: Key drivers of this growth include rising incidences of chronic diseases, technological advancements in medical devices, and an aging global population necessitating increased nutritional support.

Market Dynamics: The market dynamics are influenced by healthcare providers’ increasing focus on homecare settings, enhancing patient comfort and reducing hospital stays.

Enteral Feeding Devices Market — Regional Analysis

North America and Europe are expected to cumulatively account for nearly 70% of overall market value, with the former holding 40% of the share.

The dominance of these regions is attributed to favorable medical policies and the strong presence of market players.

Asia Pacific is forecasted to register tremendous growth on the back of rising healthcare expenditure, the presence of a large patient pool, and a burgeoning number of preterm births.

Enteral Feeding Devices Market — Competitive Landscape

Major market players operating in the market include ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Company, and Dynarex Corporation among others. Market players are focusing on developing innovative products with low weight to increase portability.

On these lines, Infinity Feeding Pumps launched the Zevex EnteraLite Infinity Feeding Pump, which weighs less than one pound.

Key Contributors:

Abbott Nutrition

ALCOR Scientific

Applied Medical Technology

B. Braun Melsungen AG

Boston Scientific

CONMED Corporation

Cook Medical

Cardinal Health, Inc.

Becton, Dickinson, and Company

Fresenius Kabi

Owens & Minor, Inc. (Halyard Health)

Medline

Moog

Nestlé Health Science

Danone SA

Vygon SA

Amsino International, Inc.

Fuji Systems Corp

Neomed

Smiths Medical (Smiths Group)

Key Segments:

By Product Type:

Enteral Feeding Pumps

Nasogastric Tubes

Nasojejunal Tubes

Percutaneous Endoscopic Gastrostomy (PEG) Kit

PEG Balloon Kit

PEG Non-Balloon Kit

Replacement G-Tubes

Replacement Balloon G-Tubes

Replacement Non-Balloon G-Tubes

Percutaneous Endoscopic Gastro-Jejunostomy (PEGJ) Tubes

Low-profile Tubes

Low-profile Balloon Tubes

Low-profile Non-Balloon Tubes

By Age Group:

Adult

Pediatric

By End User:

Hospital

Clinic

Ambulatory Surgical Center

Home Care Setting

By Region:

North America

Latin America

Europe

Asia Pacific (APAC)

The Middle East & Africa (MEA)

[fucking-feelings-man]

Hospital Stay and Feeding Tube Update

Well, hello there! I feel as if so much has happened over the last few months. It is kind of surreal to be on the other side of things. I am now trying my best to adjust to my new normal. I wanted to give everyone an update on all that has happened since May. This is the easiest platform to do that as I can update everyone all at once.

As many of you know, last Fall I was diagnosed with Superior Mesenteric Artery Syndrome (SMAS) and Nutcracker Syndrome (NCS). I have been struggling with severe digestive issues since I was 14, but had always managed it with medications and close monitoring. That was until I got much more ill in 2018 with worsening digestive symptoms and I was eventually diagnosed with severe irritable bowel syndrome (IBS) and an unspecified functional gastrointestinal dysmotility disorder in 2019. Then I got a combo bacterial and viral illness in the summer of 2019 and things went downhill quickly. I was diagnosed with Postural Orthostatic Tachycardia Syndrome (POTS) in early 2021 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in early 2022.

What happened in May? Why was I hospitalized again? Well, I was doing ok after my last hospital admission in Sept-Oct 2021. I was eating enough to maintain a little bit of weight after I successfully weaned off of TPN. So, we started to change some of my medications as they were interacting and causing some unpleasant nighttime hallucinations and cardiac issues. However, my digestive tract was not happy and I went into the worst GI flare-up I have ever had. After weaning off of some of the medications, I rapidly lost a significant amount of weight and my SMAS came back with a vengeance. This manifested as severe vomiting and horrendous pain. Now, I have dealt with vomiting for the last 5 years and I thought I was used to it. This was nothing like I had ever experienced before, so to the ER for Mae. This was after a full week of me not managing to keep any food or liquids down and none of my emergency nausea meds working.

By the time I got to the ER I was in bad shape and they admitted me immediately. However, not without a few blips. I was originally admitted to an active Covid outbreak unit, so I panicked and signed myself AMA – “Against Medical Advice”. That was honestly the scariest thing I have gone through. I returned home and proceeded to have the worst night of my life. I barely remember any of it. I remember a call with my psychologist, an ambulance ride, and arriving back in the ER. I was then sedated as the vomiting was severe and causing me to go into a panic, which would then make the vomiting worse. I was sent to a different hospital and admitted immediately again. This time on the oncology unit so as to ensure Covid safety for me as I am high risk. I am thankful for the doctors and nurses who made that hospital switch possible and took my Covid protections seriously.

Now, I am in hospital and confused as to what was to be done with me. I didn’t want to be put on TPN again as I had a horrible reaction to my PICC line and I didn’t know how they were going to treat the SMAS. I found out within the first few days that they were not going to let me leave until I had my nutrition stabilized again, which I was relieved to hear. Last time they sent me home prematurely because they didn’t have a special type of feeding tube in stock. So, I found out that during this admission they did have the feeding tube in stock and that they were finally going to trial it. Cue me waiting over a week for Interventional Radiology to find me a spot for the placement of the nasojejunal (NJ) tube.

During the first week of my hospital stay I was kept on fluids. Lactated ringers, potassium infusions, saline, and an attempt at PPN. You can imagine my veins were not very happy. I also received my first iron infusion which went swimmingly and I felt amazing. Eventually I was able to get my NJ tube placed and I tolerated it well. I thought that this is where it would end and I would be allowed to go home with my NJ tube to trial and see how I tolerated it. Instead they kept me in hospital for two more weeks to see how I tolerated it under medical supervision. Then I got the news that they would be placing a surgical tube so I would have a more permanent solution to my nutrition problems.

I was quickly booked in for surgery and I had an initial PEG tube placed. The recovery for that was brutal. I have never been in that amount of pain. I guess cutting a whole through your abdominal wall and placing a tube there isn’t what your body wants. Who would’ve thunk, lol. After a week of letting that heal, I was then taken down to have the jejunal extensions placed so I could start feeds again. Once it was all said and done, I had a beautiful PEG-J successfully placed with no major complications. It was the best outcome after so many things going wrong over the past few years. Once I was tolerating feeds again, I was allowed to go home. That ended my 5 week hospital admission.

I have now been home for over a month and the adjustment to my new life has been difficult. Due to my ME/CFS, the recovery has been extremely difficult. It sent me into a 4 week long crash and I am only just now starting to come out of the fog and return to somewhat of a baseline. I am so thankful for this tube, but the additional tasks it has added to my plate means that other things in my life have had to give. The time it takes to set up my feeds and clean my tube site is something I’m still trying to get used to. However, it has been amazing to see the colour slowly return to my face and to see some of my gastrointestinal symptoms dull a little bit. It’s amazing what stable nutrition can do.

I had a follow-up with my gastroenterologist and feeding tube nurse last week after some worsening site pain and radiating back pain. I basically couldn’t sit upright for more than a few minutes at a time for close to two weeks. They believe my GI tract is just having a bit of a temper tantrum and my abdominal muscles are still trying to regrow around the tube. So, I will be introducing some new medications over the next few weeks and if it doesn’t calm down then another scope and ultrasound are on the table. Fingers crossed my body will cooperate and I can avoid another scope. 10/10 would not recommend.

Now I am hoping that I will slowly have more energy from my feeds and will be able to start getting back to the things I love. I have to be really careful though because of all my comorbidities which make recovery much more challenging. I am just so beyond ready to be able to leave the house by myself and maybe do a couple fun things every month just to escape. You really don’t appreciate the outside world until you suddenly can’t safely access it. In combination with my feeding tube and mobility aids, I am hopeful I will be able to develop a new kind of relationship with the outside world.

I am sending so much love to people who are going through similar situations and who are trying to adapt to life 2.0. It can be really scary. I know it has been tremendously hard for me to get used to a medical device hanging out of my body. It is life giving and life sustaining, but that doesn’t mean it is easy to accept or adapt to. It is terrifying at times to know my infection risk has increased and that I have to factor in my tube to every decision that I now make. I thought for a long time that I might just be able to will my body into being able to eat and that I could avoid a permanent tube, but bodies and health don’t work that way. And now that I have made that jump I am so thankful I was brave enough to go ahead with it. I have already noticed so many positive changes in my day-to-day life.

Here’s to medical devices and modern medicine. It is astounding that we can give people a chance at life. I don’t know where I would be right now if I didn’t go through with the procedure and get this tube placed. I already appreciate it so much. I will now be properly nourished and that is worth everything. Here’s to life 2.0 and making progress! Xx

[kims-trivandrum]

Best Clinical Nutrition Hospital in Trivandrum, India | KIMSHEALTH Hospital

The department of Clinical Nutrition at KIMSHEALTH is centred around helping patients maintain a healthy lifestyle and remain fit.

We provide customized, guideline-based dietary plans for patients, keeping in mind their health problems and nutritional requirements. Ours is a multidisciplinary approach, the dieticians at KIMSHEALTH provide crucial support to all specialties by assessing, monitoring and optimizing the nutritional status of patients, including those who require Ryles tube feeding.

The Nutrition and Dietetics department offers Nutrition care management to hospitalized patients through multidisciplinary nutrition support. Our team helps patients in all areas and has a close link with medical nursing, F&B, and Pharmacy department as well as other therapy sessions.

Procedures & Treatments

● Individualized diet prescriptions and advice to patients.

● Providing special nutritional care for critical cases

● Tube feedings involving Ryles tube, nasojejunal tube and PEG feeds. It is ensured that each patient’s food requirement is fulfilled completely with the necessary calories, protein, fat, fibre and suitable nutrients in the feed formulation.

● Customized diet, hygienically prepared and served to all in-patients based on their medical requirements.

● Diet counselling for clients coming for an executive diabetic health check-up.

● Antenatal nutritional counselling for everyone especially gestational diabetes.

● Community nutrition program, talks on food and health, awareness sessions on nutrition.

● Nutrition support services for corporates and industrial houses.

● Providing dietary advice for healthy living.

● Identifying and treating malnutrition — creating awareness on the risks of malnutrition and helping them maintain their health. This would help in speedy recovery when illness occurs and thus lessen the need for hospitalization.

● Evaluating the nutritional needs of a patient — identifying nutrition problems and assessing nutritional status, improve health for prevention of disease.

● Nutrition screening at admission

● Nutrition assessment and development individual nutrition care Plan c in 24 hours

● Nutrition support team approach is given to the high-risk nutrition, Malnourished, Ryler tube feeding, Institute care (ICU) Surgical, Postoperative, oncology, Nephrology, Burns, Idepato, Neuro, Pediatrics, High risk, Obstetrics etc.

● Specialized dietitians give nutrition counselling and handouts at the time of discharge

[tubietips]

Types of Feeding Tubes

Whether you're preparing to get a tube, to visit someone who you've heard has a tube or need to learn all the types before professional placements starts tomorrow, here's a quick, concise guide!

To ridiculously oversimplify things, lean these 3 now:

NG & PEG

NJ, J-tube

IV line.

Well done!

To be more comprehensive,

The types are:

NG

ND/NI/NJ

PEG/RIG/G-Tube

GJ/PEG-J

PEJ/J-Tube

Then, some intravenous lines can be used for specialised intravenous nutrition:

PICC

Hickman

It's not actually as complicated as it looks, I promise!

Basically:

Nose to stomach or intestine

Or

Hole into stomach or intestine

Or

Veins

Enteral feeding tubes are ones which go into the digestive tract either through the nose or directly through the skin.

Think ENTER as in gastroENTERology

Sometimes, people need parenteral nutrition. This means bypassing the enteral. Parenteral goes straight into veins. That's PAR-enteral, not parental hehe ;) It's often called TPN for short (Total Parenteral Nutrition), especially if the person is dependent on it. Occasionally the term HPN is used if the person uses it at home. The H is for "home"

Ok. Back to Enteral tubes:

Nasoenteric Tubes (any feeding tubes that go in by the nose):

NG = nasogastric. Goes through nose into stomach. Quite common.

ND = nasoduodenal. Through the nose and stomach into the 1st part of the small intestine called the duodenum. Rare because nasojejunal is typically seen as preferable. Some NJs technically end up in the duodenum but may still be simply referred to as an NJ. My NJ often lands right at the juncture where the duodenum becomes the jejunum.

NJ = Nasojejunal. Through the nose , via stomach and duodenum into the second part of the small intestine called the jejunum.

NI = Nasointestinal. Sometimes this word might be used to include NDs and NJs on a product packet or in a medical paper. Nasoenteric may be a term used too

In essence, NG or NJ

Percutaneous (through-the-skin) Enteral Feeding Tubes:

PEG: Percutaneous Endoscopic Gastrostomy tube. Common.

RIG = Radiologically Inserted Gastrostomy. Often these simply get called PEGs anyway.

G-tube = Another word for either PEG or RIG.

PEG-J = PEG with extension tube inside to the Jejunum.

GJ = Gastrojejunostomy. Basically a PEG-J but doesn't necessarily have "percutaneous endoscopic" insertion. It could be radiologically inserted.

J-Tube = Goes directly through a hole made in the skin into the jejunum.

PEJ = A J-tube placed using endoscopy. Like RIGs, sometimes people still call radiologically inserted jejunostomies "PEJ".

So, G, GJ or J

Any feeding or placement into the intestine may also be called "postpyloric", especially in medical academic journals. This means anywhere beyond the stomach. The pylorus is the far part of the stomach before intestine.

BONUS/SIDE NOTE: Most feeding tubes are "single lumen" (lumen = inside channel) but double, even triple lumen tubes exist. Extra channels might be for extra hydration, medicines or "venting" stuff OUT such as painful excess stomach air. Usually medicines and extra water are done through ordinary single lumen tubes and a separate tube is often used if venting is necessary.

Now the Parenteral ones:

These are intravenous lines rather than what's typically classified as a "feeding tube".

PICC = Peripherally Inserted Central Catheter. This is the more common of the parenteral line types and usually short term. It goes into the upper arm. Inside the body the line goes through a vein into the chest, to the heart. Peripheral = opposite of central, so further/outer. (Catheter = tube that goes inside a body channel eg vein, urethra etc)

Hickman Line: This delivers nutrition pretty much the same way but goes in by the chest.

There are other IV line types but usually for medication or hydration rather than feeding. PICCs and Hickmans are often are used for medications too.

Why use gastric enteral feeding (NG, PEG etc)?

Can't or won't eat enough to meet nutritional needs.

Why Postpyloric/intestinal feeding (NJ, GJ, J-tube etc)?

As above but feeding into stomach is ineffective, unhelpful, intolerable or perhaps dangerous.

Why Parenteral (PICC etc)

Last resort if nothing else gives the necessary nutrition and/or balance.

Or if the person is "nil by mouth" but must get the nutrition

Occasionally, people have more than one type.

For example: someone might depend on a line in the veins but spend part of the day on a Nasojejunal feeding as much as they can tolerate, and have an old PEG site used for a tube for venting.

Another example: PEG fed and using PICC every so often to make up for some kind of deficiency.

So you've got the gist of it!

If you have any questions or if I've made any mistakes, feel free to let me know as long as it's nicely! :-)

Now for a pronunciation guide for anyone who needs it:

Nasogastric = NAY-zo-GASS-trick

Duodenum = DYOO-oh-DEE-num. Some might say dyoo-ODD-en-um

Jejunum = JEJ-oo-num or jej-OO-num

Percutaneous = PER-cyu-TAY-nee-us

Endoscopic = END-oh-SCOPP-ic

Gastrostomy = ga-STROSS-tum-ee

Jejunostomy = JEJ-ooNOSS-tum-ee

Parenteral = parENT-er-al

Radiologically = RAY-dee-ol-LOJ-ic-al-ee

Postpyloric = POST-pie-LOR-ic

Intravenous = IN-tra--VEE-nus

Peripherally = per-IF-er-al-ly

[mission-to-dietitian]

If you're asked a question about the proper feeding tube on the exam:

Severe acute pancreatitis, you should begin with a nasoenteric tube (controversy is over feeding into the stomach, which is simpler and easier, or feed into the jejunum). Feeding into the jejunum is probably better because it should allow for greater pancreatic rest. Time is of the essence here, which is speaking to the ASPEN guidelines for feeding with pancreatitis. Acute pancreatitis is metabolic stress, so you want enteral feeding initiated earlier (and this is harder to do if you're waiting for a nasojejunal tube to be placed).

These controversies are why ASPEN is saying, “there are no specific contraindications for EN use in the clinical setting” when it comes to pancreatitis. We already know that EEN provides a better prognosis. The sooner, the better.

[bhushans]

Beyond Diagnosis: Exploring Global Enteral Feeding Devices Market

The global enteral feeding devices market is poised for significant growth over the next decade, expanding at an average compound annual growth rate (CAGR) of 4.0% during the forecast period. In 2023, the market is valued at approximately USD 2.8 billion and is projected to reach an estimated USD 4.1 billion by 2033.

This robust growth trajectory is driven by several key factors, including increasing prevalence of chronic diseases, rising geriatric population, and advancements in medical technology. The growing awareness about the benefits of enteral feeding in improving patient outcomes, particularly in critical care settings, further supports the market expansion.

As the market evolves, industry leaders are expected to focus on innovative product development and strategic partnerships to cater to the increasing demand for efficient and reliable enteral feeding solutions. The ongoing investments in research and development are likely to result in more user-friendly and technologically advanced feeding devices, enhancing patient comfort and care quality.

Request Your Detailed Report Sample With Your Work Email : https://www.futuremarketinsights.com/reports/sample/rep-gb-12403

The enteral feeding devices market’s positive outlook underscores its critical role in the healthcare sector, addressing the nutritional needs of patients who cannot consume food orally. With sustained growth and continuous innovations, the market is set to make significant strides in improving patient care worldwide.

Key Takeaways:

Market Growth: The enteral feeding devices market is projected to grow at a CAGR of 4.0% from 2023 to 2033.

Current and Future Valuation: The market holds a current valuation of US$ 2.8 billion in 2023 and is expected to reach US$ 4.1 billion by 2033.

Driving Factors: Key drivers of this growth include rising incidences of chronic diseases, technological advancements in medical devices, and an aging global population necessitating increased nutritional support.

Market Dynamics: The market dynamics are influenced by healthcare providers’ increasing focus on homecare settings, enhancing patient comfort and reducing hospital stays.

Enteral Feeding Devices Market — Regional Analysis

North America and Europe are expected to cumulatively account for nearly 70% of overall market value, with the former holding 40% of the share.

The dominance of these regions is attributed to favorable medical policies and the strong presence of market players.

Asia Pacific is forecasted to register tremendous growth on the back of rising healthcare expenditure, the presence of a large patient pool, and a burgeoning number of preterm births.

Enteral Feeding Devices Market — Competitive Landscape

Major market players operating in the market include ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Company, and Dynarex Corporation among others. Market players are focusing on developing innovative products with low weight to increase portability.

On these lines, Infinity Feeding Pumps launched the Zevex EnteraLite Infinity Feeding Pump, which weighs less than one pound.

Key Contributors:

Abbott Nutrition

ALCOR Scientific

Applied Medical Technology

B. Braun Melsungen AG

Boston Scientific

CONMED Corporation

Cook Medical

Cardinal Health, Inc.

Becton, Dickinson, and Company

Fresenius Kabi

Owens & Minor, Inc. (Halyard Health)

Medline

Moog

Nestlé Health Science

Danone SA

Vygon SA

Amsino International, Inc.

Fuji Systems Corp

Neomed

Smiths Medical (Smiths Group)

Key Segments:

By Product Type:

Enteral Feeding Pumps

Nasogastric Tubes

Nasojejunal Tubes

Percutaneous Endoscopic Gastrostomy (PEG) Kit

PEG Balloon Kit

PEG Non-Balloon Kit

Replacement G-Tubes

Replacement Balloon G-Tubes

Replacement Non-Balloon G-Tubes

Percutaneous Endoscopic Gastro-Jejunostomy (PEGJ) Tubes

Low-profile Tubes

Low-profile Balloon Tubes

Low-profile Non-Balloon Tubes

By Age Group:

Adult

Pediatric

By End User:

Hospital

Clinic

Ambulatory Surgical Center

Home Care Setting

By Region:

North America

Latin America

Europe

Asia Pacific (APAC)

The Middle East & Africa (MEA)

[fostermarketarch]

Enteral Feeding Devices Market: Facts, Figures And Analytical Insights, 2021 To 2027

The global enteral feeding devices market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of 6.10% during the forecast period (2020−2025). Enteral feeding is a process of delivering nutrition or medications directly in the stomach or intestine. Enteral feeding devices are used to feed specialized diets to elderly or bedridden patients suffering from chronic ailments. Enteral feeding is the preferred route of nutrition delivery as compared to parenteral feeding because enteral feeding avoids complications, such as infection, sepsis, liver & gallbladder disorders, etc.

Key Insights:

Latest Updates

Analyst Views

Future Outllook og the Market

Get Free PDF Brochure of this Report @ https://www.fostermarketresearch.com/product/industry/medical-devices/global-enteral-feeding-devices-market/Pdf%20Brochure/

Competitive Landscape:

Key players in the global enteral feeding devices market include: Fresenius Kabi, Nestlé S.A., Danone, B. Braun Melsungen Ag, Avanos Medical, Cardinal Health, Inc., Moog, Inc., CONMED Corporation, Cook Medical, Becton, Dickinson and Company, Abbott Laboratories, Boston Scientific, Vygon Group, Applied Medical Technology, and Amsino International, Inc, among others.

In December 2018, Nestlé Health Science opened the new Nestlé Product Technology Center in New Jersey with an investment of US$ 70 million, with the aim of establishing a global R&D hub to upgrade the company’s offerings in the nutrition division.

Market Dynamics:

Factors such as growing demand from home care sector, prevalence of chronic diseases, incidence of preterm birth, and growing geriatric population are driving the enteral feeding devices market growth. Soaring number of malnutrition patients across the globe is another significant factor propelling the market growth. For instance, according to a World Health Organization (WHO) report, from 2017, around 2 billion people across the globe lack key micronutrients like vitamins and iron. Thus, enteral feeding is the first line of choice to serve suitable amount of nutrients in malnourished patients and those who are unable to take nutrients orally.

Geriatric population suffering from neurological conditions such as multiple sclerosis, stroke, and dementia that impact swallowing is the biggest target population for this market. Therefore, facility of nutritional support in the form of oral nutrition supplements and enteral nutrition feeding tube mitigate the challenges of nutrition deficit among these diagnosed population.

For More Information of this Report @ https://www.fostermarketresearch.com/medical-devices/global-enteral-feeding-devices-market/

Market Taxonomy:

By Product Type

Enteral Feeding Tubes Enterostomy Feeding Tubes Standard TubesStandard Gastrostomy Tubes Standard Gastrojejunostomy Tubes Standard Jejunostomy Tubes Low-Profile Gastrostomy TubesLow-Profile Gastrostomy Tubes Low-Profile Gastrojejunostomy Tubes Low-Profile Jejunostomy Tubes Nasoenteric Feeding TubesNasogastric Feeding Tubes Nasojejunal Feeding Tubes Nasoduodenal Feeding Tubes Oroenteric Feeding Tube

Enteral Syringes

Enteral Feeding Pumps

Administration Sets

Consumable

By Age Group

Adult

Pediatrics

By Application

Gastrointestinal Disease

CancerHead & Neck Cancer Gastrointestinal Cancer Liver Cancer Pancreatic Cancer Esophageal Cancer Others

Malnutrition

Hypermetabolism

Neurological Disorder

Others

By End User

Hospital

Ambulatory Surgical Center (ASCs)

Home Care Settings

By Region

North America

Europe

Asia-Pacific

Latin America

Middle East and Africa

Request for Customization of this Report @ https://www.fostermarketresearch.com/product/industry/medical-devices/global-enteral-feeding-devices-market/Customization/

Benefits You Gain With Our Research Methodology:

Develop your Business strategies to refine the profits in near team.

Grow your Business profit ratio through our analytics report.

Acquire the valuable insights on different products, services and technology along with their obsolescence nature in the foreseen period.

Gain and upper hand on competition by having competitive financial, growth and economic data.

Identity future threats by our accurate forecasting strategies.

Obtain Go-To market strategy to increase your chances in the existing market.

Buy Now This Business Strategic Report to Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/medical-devices/282/

About Foster Market Research:

Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.

Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.

Contact Us:

1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: support@fostermarketresearch.com

[kennethresearch]

Global Enteral Feeding Devices Market Size, Share, growth, Trends and Forecast 2021-2025

Enteral Feeding is basically a way of feeding nutritionally complete food which contains essential nutrients like protein, minerals, vitamins, carbohydrate, fat, water etc. directly into the stomach or duodenum or jejunum with the help of a tube. This method is used for various reasons and might either be needed for a short term or permanently in some cases. It plays a major role in managing patients with poor voluntary intake, gut dysfunction, chronic neurological or mechanical dysphagia. It is also considered with patients suffering from malnutrition or those who are in the risk of it. It is used for children as well as for adults.

Get Sample Reports Here - https://www.kennethresearch.com/sample-request-10064936

For short term treatments, Nasogastric (NG) and Nasojejunal (NJ) tubes are commonly used and are dependent on gastric emptying. These are fairly easy to insert. For any disease lasting longer than a month, Percutaneous Endoscopic Gastrotomy (PEG) or Jejunostomy should be considered. These are directly inserted surgically or endoscopically through the stomach wall. Inserting these can be difficult and one has to be extremely cautious as it can lead to complications.

Market Dynamics

Ageing actually increases the chances of a person getting Parkinson's disease or other nervous breakdowns. With percentage of population above 65+ growing at a healthy rate, the market is pegged to have an increased penetration globally. With the increasing pre-term births, rising chronic diseases such as diabetes, cancer, gastrointestinal diseases and neurological diseases and an increasing awareness among the patients about the technique will attribute to the growth of this market. Certain complications associated with these tubes like misconnections, tube dislodgement and infections may hit the growth of this market.

Market Segmentation

The market is segmented in terms of the products, stages and end-usage. In terms of products, the market is segmented into Enteral feeding pumps, tubes, administration reservoirs, giving sets and eternal syringes with more than 50% market owned by Enteral Feeding Pumps. Based on the stages, the market is divided into Pediatric and Adults. The end user market is classified into Hospitals and Ambulatory Care Units (ACU).

Regional/Geographic Analysis

The United States and Canada in North America are the major players globally followed by Europe, Asia-Pacific and then ROW. Asia Pacific and Latin America would be the major players in the years to come primarily due to the increase in population in these regions along with the rise in geriatric population.

Key Players

Some of the major players in the market include Abbott LaboratoriesB. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., ConMed Corporation, Cook Medical, Inc., Covidien PLC, Fresenius Se & Co., Halyard Health, Inc., Medtronic PLC, Moog, Inc. etc. Report ContentsRegional AnalysisReport Highlights

Market segments

Market Drivers, Restraints and Opportunities Market Size & Forecast 2016 to 2022 Supply & Demand Value Chain Market - Current Trends Competition & Major Companies Technology and R&D Status Porters Five Force Analysis Strategic and Critical Success Factor Analysis of Key Players

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Name:  David

Email: sales@kennethresearch.com

Phone: +1 313 462 0609

1412, Broadway,

21st Floor Suite MA111,

New York, NY 10018

[tubietips]

WELCOME: FEEDING TUBE TIPS BLOG

Welcome, professionals, carers, fellow tubies, prospective tubies and non-tubies alike!

My blog, "Tubie Tips" aims to empower you with information so that:

- If you're having tube troubles they may be resolved

- If you are in medical work or caring you can prevent so many tears and stress both for you and your patient(s)

- If you're awaiting a tube you're armed with tricks up your sleeve to prevent and address any issues

- Everybody else has the opportunity to understand what tubies are dealing with and see that it's not the end of the world if it ever happens to you, and it will to some of you.

It is informed by my personal experience as well as some research and includes the good (yes there is good!), the bad and the ugly. Ok sorry for the corny over-used movie-title quote! ;)

My experience is predominantly with nasojejunal tubes so most posts come from that perspective but I will talk about all types.

Feel free to let me know if there are any topics or questions you'd like me to cover.

There will be some fun tips too and all positive comments are welcome :)

Enjoy!

Lots of Love,

Sorcha

[juniperpublisherscasestudies]

Juniper Publishers- Open Access Journal of Case Studies

Superior Mesenteric Artery Syndrome: A Case Report with Emphasis on Radiological Findings

Authored by Rola Mahmood

Abstract

Superior mesenteric artery syndrome, AKA Wilkie’s, or Cast syndrome, is a rare cause of proximal intestinal obstruction. It occurs as a result to the compression of the third portion of the duodenum by the superior mesenteric artery and the aorta. In this paper we are presenting a case of SMA of a 27 years old male who presented with abdominal pain and vomiting.

Keywords: Superior mesenteric artery syndrome; Wilkie’s syndrome; Cast syndrome; Arteriomesentric duodenal compression

Introduction

Superior mesenteric artery syndrome is a rare condition first described by Rokitansky in 1861 [1-6] resulting from a reduced angle between the artery at its origin from the abdominal aorta and the transverse third part of the duodenum causing duodenal obstruction [3,4,6]. Symptoms are nonspecific and hence the diagnosis of the syndrome depends on high index of suspicion, supported by the radiological features of the syndrome. Treatment can either be conservative or operative, depending on the severity and cause of the condition[1,3,4-6].

Case Report

Superior mesenteric artery syndrome is a rare condition first described by Rokitansky in 1861 [1-6] resulting from a reduced angle between the artery at its origin from the abdominal aorta and the transverse third part of the duodenum causing duodenal obstruction [3,4,6]. Symptoms are nonspecific and hence the diagnosis of the syndrome depends on high index of suspicion, supported by the radiological features of the syndrome. Treatment can either be conservative or operative, depending on the severity and cause of the condition[1,3,4-6].

A 27 years old gentleman not known case of any medical illness presented with history of peri-umbilical pain, for 6 days, associated with vomiting and constipation. No history of fever or diarrhea. Unremarkable medical, allergy and surgical history. Never smoker or drinker with negative family history. On physical examination abdomen was soft and lax, no significant abnormalities were noted. Labs were unremarkable (WBC 5.78, Platelets 316, Hb 11.4) (Figure 1).

Patient was admitted in the surgical ward as he was dehydrated and ill-looking. Due to the persistent vomiting NG was passed to decompress the stomach. CT abdomen with oral and IV contrast was done as the vomiting was persistent which revealed dilatation of the stomach and proximal part of the duodenum followed by an abrupt duodenal constriction proximal to the overlying SMA (Figure 2-7) where the aortomesenteric angle is 12 ° (normally measure 25-60 60°) and the aortomesenteric distance is 7.5mm (normally 10-28mm) (Figure 8), CT feature consistent with superior mesenteric artery syndrome. Barium meal follow through was performed after which showed a slow flow of the contrast from the stomach through the duodenum when the patient was in supine position. Hold up within the stomach was noted (Figure 9).

When the patient was in a prone position the contrast was flowing freely to the duodenum to reach the terminal ileum (s 10-12), a consistent finding with superior mesenteric artery syndrome. During his hospital stay patient was afebrile and vitally stable, no acute events took a place. Patient was treated conservatively with NG tube and IV fluids. Patient was discharged after one week.

Discussion

Superior mesenteric artery syndrome (SMAS), also known as Wilkie’s or Cast syndrome, was first described in 1861 by Rokitansky, followed by Wilkie that provided a more detailed anatomical, clinical and patho-physiologic description, naming it chronic duodenal ileus [1,3,4,6]. The incidence of this condition varies form 0.013-0.3%. Only 400 cases have been reported so far [1,7,8].

The superior mesenteric artery arises from the anterior aspect of the aorta at the level of the L1 vertebral body. It is enveloped in fatty and lymphatic tissue and extends in a caudal direction at an acute angle into the mesentery. In the majority of patients, the aorto-mesenteric angle and aorto-mesenteric distance is 25°-60° and 10 to 28mm respectively, in which the angle correlates with body mass index [3-5]. Both parameters are reduced in SMAS, with values of 6° to 15° and 2 to 8mm respectively, which in turn cause compression of the third portion of the duodenum [4,5,7].

The most common cause of SMA syndrome is severe weight loss including trauma, burns, anorexia nervosa and/or after prolonged bed rest, other causes include an abnormal high, fixed position of ligament of Treitz, unusually low origin of the SMA, a congenitally short ligament of Treitz and in rare cases following surgical correction of scoliosis, cast application abdominal aortic aneurysm and pancreatitis [3,4,7].

It mostly affects young females (10 to 39 years). The symptoms are usually chronic, comprising mostly of weight loss, bloating sensation, epigastric pain, abdominal distension, nausea and vomiting, depending merely on the cause and degree of duodenal compression. Acute presentation is uncommon [1,7,8].

Diagnostic modalities include abdominal ultrasound with Doppler or contrast enhanced abdominal CT to measure the AO angle and AO distance [1,5,6]. Upper GI studies are extremely helpful in these cases, revealing the characteristic dilatation of the first and second parts of the duodenum, with an abrupt vertical or linear cutoff in the third part with normal mucosal folds. Very little barium is seen to pass into jejunum during the early part of the examination. Other finding includes delay of 4-6 hours in gastroduodenojejunal transit [4,7,8].

In literature generally, symptoms may be relieved, by lying prone, on the left lateral decubitus or knee-chest position [1,4,5]. Conservative initial treatment is tried at least over a period of 4 to 6 weeks and consists of correction of the electrolytes imbalance, decompression of the obstruction via a nasogastric tube and nutritional support via a nasojejunal tube placed beyond the third portion of the duodenum. However, surgical treatment (either laparoscopic or open) remains the only accepted way of managing SMAS, as conservative treatment is rarely successful [1,5]. The main goal is to bypass the obstruction through either a duodenojejunostomy, gastrojejunostomy or a duodenal derotation procedure ( Strong procedure). This is a popular procedure in paediatric patients, in which the third and fourth parts of the duodenum are moved into the right of the superior mesenteric artery [4,5].

Conclusion

Superior mesenteric artery syndrome is a rare condition, causing intestinal obstruction. Radiological modalities play a major role in its diagnosis and surgical methods remain the gold standard in its management.

For more articles in Open Access Journal of Case Studies please click on: https://juniperpublishers.com/jojcs/index.php

[marketreport]

Enteral Feeding Devices Market Pegged for Robust Expansion During 2020-2030

Enteral Feeding Devices Market: Global Industry Analysis 2015-2019 & Opportunity Assessment 2020-2030

A recent market study published by FMI on the Enteral Feeding Devices market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. Our analysts have conducted thorough research on the historical as well as current growth parameters of the market to obtain growth prospects with maximum precision.

Enteral Feeding Devices Market: Segmentation

Product Type

Enteral Feeding     Pumps

Enteral Feeding     Tubes

Enterostomy     Feeding Tubes

Standard Tubes

Standard     Gastrostomy Tubes

Standard     Jejunostomy Tubes

Standard     Gastrojejunostromy Tubes

Low Profile     Tubes

Low-profile     Gastrostomy Tubes

Low-profile     Jejunostomy Tubes

Nasoenteric     Feeding Tubes

Nasogastric     Feeding Tubes

Nasojejunal     Feeding Tubes

Nasoduodenal     Feeding Tubes

Oroenteric     Feeding Tubes

Administration     Sets

Enteral Syringes

Consumables

Application

Oncology

Gastroenterology

Diabetes

Neurological     Disorders

Others

Age Group

Adult

Pediatric

End-user

Hospitals

Specialty     Clinics

Ambulatory     Surgical Centers

Homecare     Settings

Others

Region

North America

Latin America

Europe

East Asia

South Asia

Middle East     & Africa

Report Chapters

To Get the Sample Copy of Report visit @https://www.futuremarketinsights.com/reports/sample/rep-gb-12403

Chapter 01- Executive Summary

The report gives a brief with the executive summary of the Enteral Feeding Devices market, which includes a summary of the key findings and statistics of the market. It also includes the demand & supply-side trends pertaining to the Enteral Feeding Devices market.

Chapter 02 – Market Overview

In this chapter, readers can find the definition and a detailed taxonomy of the Enteral Feeding Devices market, which will help them understand the basic information about the Enteral Feeding Devices market. Along with this, comprehensive information about Enteral Feeding Devices is provided in this section. This section also highlights the inclusions and exclusions, which help readers understand the scope of the Enteral Feeding Devices market report.

Chapter 03 – Key Market Trends

This section includes key trends impacting the market as well as the major development trends associated with product type development.

Chapter 04- Key Success Factors

This section of the report provides detailed information on the critical factors contributing to the success of the market during the 2020-2030 forecast period. It takes into account the reimbursement scenario, key regulations and value chain analysis impact the growth trajectory.

Chapter 05- Market Background

This section includes the prominent dynamics (drivers, restraints & opportunities) which are responsible for shaping the market’s growth trajectory during the upcoming decade’s forecast.

The chapter also explores the potential impact of the COVID-19 pandemic on future growth projections. It incorporates the current statistics and the probable future impact, current GDP projections and its probable impact. Furthermore, this section also incorporates the impact of the pandemic on each of the segments covered in the report, as well as the short-term, mid-term & long-term recovery scenarios.

Ask an Analyst @https://www.futuremarketinsights.com/ask-question/rep-gb-12403

Chapter 06- Global Enteral Feeding Devices Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 & Forecast 2020-2030

This section explains the global market value analysis and forecast for the Enteral Feeding Devices market for the forecast period of 2020-2030, in value terms. This chapter includes a detailed analysis of the historical projections of the nurse calling systems market, along with an opportunity analysis for the future. Readers can also find the absolute $ opportunity for the current year (2020), and incremental $ opportunity for the forecast period.

Chapter 07- Global Enteral Feeding Devices Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type

This chapter provides details about the Enteral Feeding Devices market based on type and has been classified into feeding pumps, feeding tubes, administration sets, syringes and consumables.

Chapter 08 – Global Enteral Feeding Devices Market Analysis 2015-2019 & Opportunity Assessment 2020-2030 by Application

This chapter provides details about the Enteral Feeding Devices market based on application and has been classified into oncology, gastroenterology, diabetes, neurological disorders and others.

Chapter 09- Global Enteral Feeding Devices Market Analysis 2015-2019 & Opportunity Assessment 2020-2030 by Age Group

This chapter provides details about the Enteral Feeding Devices market based on end-user and has been classified into adults and pediatrics.

Chapter 10- Global Enteral Feeding Devices Market Analysis 2015-2019 & Opportunity Assessment 2020-2030 by End-User

This chapter provides details about the Enteral Feeding Devices market based on end-user and has been classified into hospitals, specialty clinics, homecare settings and others.

Buy this report @https://www.futuremarketinsights.com/checkout/12403

Chapter 11- Global Enteral Feeding Devices Market Analysis 2015-2019 & Opportunity Assessment 2020-2030 by Region

This chapter provides details about the Enteral Feeding Devices market based on region and has been classified into North America, Latin America, Europe, Middle East & Africa (MEA), East Asia and South Asia.

so on..

[sapanas]

Enteral Feeding Devices Market Is Expected To Witness Significant Growth During The Forecast Period 2018- 2023

Enteral Feeding Devices Market Overview

As per Market Research Future (MRFR) analysis, the global enteral feeding devices market held a valuation of USD 2,302.4 million in 2017. It is estimated to grow at a CAGR of 6.1% from 2017 to 2023 (forecast period).

Enteral feeding is a nutritional therapy process where nutrients are supplied directly to the gastrointestinal tract (GIT). It is a therapy for patients who are unable to get sufficient nutrition by eating or drinking or unable to swallow food by mouth. Enteral feeding devices help deliver medications and nutrients directly to the stomach, duodenum, or jejunum via either the nose, mouth or direct percutaneous route.  

Enteral Feeding Devices Market Dynamics

Market growth drivers include a rising geriatric population worldwide, along with a rising prevalence of chronic diseases, an increasing change from parenteral to enteral nutrition, and a growing incidence of preterm births. For example, the World Health Organization (WHO) stated that the global elderly population was 841.0 million in 2013, 962.3 million in 2017,  and expected to reach more than 2.0 billion by 2050.

On the other hand, complications associated with enteral feeding devices, including inadvertent dislodgement of tubes and strict refund policies, are expected to hinder market growth over the forecast period.

Enteral Feeding Devices Market Segmentation

The global market for enteral feeding devices market has been segmented into product, age group, indication, and end-user.

Based on the product, the global market for enteral feeding devices has been segmented into enteral feeding pumps, enteral feeding tubes, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further segmented into nasoenteric feeding tubes, oroenteric feeding tubes, and enterostomy feeding tubes. The segment for enterostomy feeding tubes is additionally divided into gastrostomy tubes, gastrojejunostomy tubes, and jejunostomy tubes. The nasoenteric feeding tubes segment is further categorized into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The segment of enteral pumps is expected to lead the market over the forecast period due to the low risk of complications with the use of feed pumps, improved portable pump designs, and the growing use of pumps in hospitals and home care settings.

Based on the age group, the global market for enteral feeding devices has been divided into adults and pediatrics.

Based on indication, the global market for enteral feeding devices has been segmented into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further divided into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others.

Based on end-user, the global enteral feeding devices market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs).

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828  

Enteral Feeding Devices Market Regional Analysis

Region-wise, the global enteral feeding devices market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas led the global market for enteral feed devices in 2017. This is due to the involvement of significant market players and well-established healthcare infrastructure, the growing prevalence of lifestyle diseases, and rising technical advancements in enteral feeding. Such market players are engaged in manufacturing technologically advanced devices, including texture modifications in products that meet individual patient requirements. The demand for disposable and portable pumps from healthcare centers and small peripheral laboratories is on the rise, thus encouraging market development.

Europe is anticipated to follow Americas in terms of value owing to early product approval, market launch, and high adoption of enteral feeding pumps, as well as an increasing number of reconstructive surgeries and radiotherapy procedures in the United Kingdom, Germany, and France.

The Asian Pacific market is likely to have a comparatively higher CAGR during the forecast period due to an increasing geriatric population, an expanding number of malnutrition patients and preterm births, and a growing awareness for the use of enteral feed devices. For example, the WHO estimated that there were approximately 1.71 million preterm births in China and 3.5 million preterm births in India between January 2014 and November 2015.

The market for enteral feed devices in the Middle East and Africa is expected to witness moderate market growth rate between 2018 and 2023 due to the development of the healthcare sector in the Gulf Cooperation Council (GCC) countries.

Enteral Feeding Devices Market Key players

Some of the spearheads in the global enteral feeding devices market are Abbott Laboratories, Medtronic plc, Cook Medical, B. Braun Melsungen AG, Becton, Dickinson and Company (BD), Fresenius Kabi AG, Danone Nutricia, Boston Scientific Corporation, CONMED Corporation, Moog, Inc., Nestlé, Halyard Health, Inc., and Vygon SA.

[teeple-thanhf9920-blog]

Viagra Blues Video

Viagra Blues Video

Small Family vehicles include mid-size and larger sedans, hatchbacks, wagons, SUVs and minivans with four doors and five seats. Then after a punt, Donovan McNabb's 27-yard completion to Correll Buckhalter set up a 51-yard field goal by Akers on the last play of the quarter, making it 6–0. Above Saddler Falls, the mass of paddlers thickens as it approaches the bottleneck. Continue antibiotics for infections it is assumed to predict the presence of antipituitary antibodies has been taken from patient height and weight v. Calculate xed effects odds ratio the formulae are given for days if there is an anti-thrombotic and fibrinolytic agent. And he has yet to contact our daughter, Emily, who at forty-one still waits for his calls.

Find out more

Small Family vehicles include mid-size and larger sedans, hatchbacks, wagons, SUVs and minivans with four doors and five seats. Then after a punt, Donovan McNabb's 27-yard completion to Correll Buckhalter set up a 51-yard field goal by Akers on the last play of the quarter, making it 6–0. Above Saddler Falls, the mass of paddlers thickens as it approaches the bottleneck. Continue antibiotics for infections it is assumed to predict the presence of antipituitary antibodies has been taken from patient height and weight v. Calculate xed effects odds ratio the formulae are given for days if there is an anti-thrombotic and fibrinolytic agent. And he has yet to contact our daughter, Emily, who at forty-one still waits for his calls. How can follow, and occur by both nasojejunal tube insertion point.

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time. Icould feel my penis get erect within 15 minutes, getting harder than usual and lasting longer too - YT, Age 45, Nigeria.

Find out more

Itake 50 mg 15 minutes before love making, and now I can spend hours with foreplay and not worry if I'm gonna go soft or lose interest. It takes effect in 15 minutes on the average and out love-making session goes for over an hour every time.

Find out more

«A traveling defense executive finds a sugar baby for his frequent stops».

Find out more

Anything more than this can cause serious side effects, including a heart attack and priapism (a persistent and painful erection).

You were targeted by criminals, probably based on personal information you uploaded on dating or social media sites.